fialuridine has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, R; Lang, J; Liu, Y; Sun, X; Wu, T; Zhang, B | 1 |
Blasberg, R; Burgman, P; Cai, S; Finn, R; Gelovani, J; Li, GC; Ling, CC; O'donoghue, J; Serganova, I; Wen, B; Zanzonico, P | 1 |
Prince, AM | 1 |
Borrelli, E; Hindelang, C; LeMeur, M; Mathis, C | 1 |
4 other study(ies) available for fialuridine and Disease Models, Animal
Article | Year |
---|---|
Monitoring bone marrow stem cells with a reporter gene system in experimental middle cerebral artery occlusion rat models.
Topics: Animals; Arabinofuranosyluracil; Autoradiography; Behavior, Animal; Bone Marrow Cells; Disease Models, Animal; Feasibility Studies; Genes, Reporter; Herpesvirus 1, Human; Infarction, Middle Cerebral Artery; Isotope Labeling; Male; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Stem Cells; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon | 2013 |
A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Feasibility Studies; Fluorine Radioisotopes; Gene Expression Profiling; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Misonidazole; Nuclear Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Thymidine Kinase; Transcription Factors; Viral Proteins | 2004 |
Severe toxicity of fialuridine (FIAU)
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis; Humans; Marmota; Pan troglodytes | 1996 |
A transgenic mouse model for inducible and reversible dysmyelination.
Topics: Animals; Antigens, Differentiation; Arabinofuranosyluracil; Blotting, Northern; Brain; Demyelinating Diseases; Disease Models, Animal; Female; Glial Fibrillary Acidic Protein; Gliosis; Herpesvirus 1, Human; In Situ Hybridization; Male; Mice; Mice, Transgenic; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Optic Nerve; Promoter Regions, Genetic; Recombinant Fusion Proteins; RNA, Messenger; Sciatic Nerve; Thymidine Kinase | 2000 |